Stock 300396 DIRUI INDUSTRIAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dirui Industrial Co.,Ltd.

Equities

300396

CNE100001XS7

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
24.65 CNY +1.90% Intraday chart for Dirui Industrial Co.,Ltd. -0.80% -16.30%
Apr. 18 Dirui Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 12 Dirui Industrial Gets Nod to Register 19 Devices MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 4,910 6,727 8,034 6,721 - -
Enterprise Value (EV) 1 4,910 6,727 8,034 6,721 6,721 6,721
P/E ratio 23.6 x 25.9 x 29.2 x 15.6 x 11.4 x 9.1 x
Yield - 1.95% 1.7% 1.78% 2.41% -
Capitalization / Revenue - 5.51 x 5.83 x 2.91 x 2.25 x 1.75 x
EV / Revenue - 5.51 x 5.83 x 2.91 x 2.25 x 1.75 x
EV / EBITDA - 23.7 x 24.1 x 13.9 x 10.2 x -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - 3.53 x 3.97 x 1.92 x 1.94 x 1.25 x
Nbr of stocks (in thousands) 273,987 273,337 272,791 272,659 - -
Reference price 2 17.92 24.61 29.45 24.65 24.65 24.65
Announcement Date 4/28/22 4/17/23 4/18/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 1,220 1,378 2,311 2,981 3,849
EBITDA 1 - 283.5 333.7 483.5 662 -
EBIT 1 - 292.2 296.9 496 662.5 830.4
Operating Margin - 23.95% 21.54% 21.46% 22.22% 21.57%
Earnings before Tax (EBT) 1 - 291.4 296.2 495.7 661.9 829.9
Net income 1 209.9 261.7 275.6 433.4 594 743.3
Net margin - 21.45% 20% 18.75% 19.92% 19.31%
EPS 2 0.7600 0.9500 1.010 1.580 2.163 2.710
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - 0.4800 0.5000 0.4400 0.5950 -
Announcement Date 4/28/22 4/17/23 4/18/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - 13.7% 13.8% 12.3% 17.9% 13.8%
ROA (Net income/ Total Assets) - 9.87% - 12.2% 14.4% -
Assets 1 - 2,650 - 3,555 4,115 -
Book Value Per Share 2 - 6.980 7.420 12.80 12.70 19.70
Cash Flow per Share 2 - 0.1500 0.8200 -0.2200 1.370 -0.6500
Capex 1 - 9.87 32.7 26.5 27 -
Capex / Sales - 0.81% 2.37% 1.15% 0.91% -
Announcement Date 4/28/22 4/17/23 4/18/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Dirui Industrial Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
24.65
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
DIRUI INDUSTRIAL CO.,LTD. Stock Dirui Industrial Co.,Ltd.
-16.30% 927M
BIOMÉRIEUX Stock bioMérieux
+0.89% 12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-10.29% 7.61B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-1.16% 4.51B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+5.74% 4.49B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.70% 3.3B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+12.21% 2.73B
VITROLIFE AB Stock Vitrolife AB
-16.13% 2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-11.50% 1.73B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
-5.02% 1.64B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 300396 Stock
  4. Financials Dirui Industrial Co.,Ltd.